OCULUS INNOVATIVE SCIENCES I's ticker is OCLS and the CUSIP is 67575P207. A total of 15 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $2,000 | – | 855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Wealth Advisors, Inc. | 117,206 | $276,000 | 0.04% |
| Madden Advisory Services, Inc. | 475 | $1,000 | 0.00% |
| UBS AG | 1,930 | $5,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 3,270 | $8,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,225 | $10,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 6,371 | $15,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 24,497 | $57,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 142 | $0 | 0.00% |
| CITIGROUP INC | 326 | $0 | 0.00% |
| MORGAN STANLEY | 3,237 | $8,000 | 0.00% |